CD79a

Methodology

Immunohistochemistry (IHC)


Test Description and clinical significance

Disease:
General detection of B cells/B cell origin (with CD20);
In ALL or small B cell lymphoproliferative disorders when CD20 may be negative,
In infarcted lymphomas, differentiate preB lymphoblastic lymphoma from Ewing’s sarcoma

Also called MB-1, B cell antigen receptor complex associated protein alpha-chain
Encodes Ig-alpha protein of the B cell antigen receptor; the receptor also includes Ig-beta protein (CD79b) and surface immunoglobulin
Expressed early in B cell differentiation (often positive when mature B cell markers are negative); also expressed in plasma cells
In AML, presence usually represents aberrant B cell antigen in leukemias of distinct myeloid linage, not biphenotypic differentiation
CLL patients have low B cell-IgM surface expression due to defects in glycosylation and folding in µ and CD79a chains


Specimen Requirements

Collection:
FFPE/un-stained slides/Fresh tissue in formalin

Stability:
Room temperature

Unacceptable Conditions:
Unlabeled specimen/specimen left unfixed
for extended periods


Storage & Transport

Room Temperature


CPT(s)

88342 if intial single stain or 88341 for each additional stain CD79a


New York Approved

NO


TAT

1 Day


*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.

Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.